25021-0465 Octreotide Acetate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

25021-0465

Brand Name:

Octreotide Acetate

Generic Name:

Octreotide acetate

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: OCTREOTIDE ACETATE

Strength: 500.0

Unit: ug/mL

Packages:

Code: 25021-0465-01

Description: 10 VIAL in 1 CARTON (25021-465-01) / 1 mL in 1 VIAL

Effective Date: June 15, 2023

Discontinued:

SEER*Rx Category:

Hormonal Therapy

Major Class:

Somatostatin Analog

Minor Class:

Orphan Drug Designation:

Status:

In Use